BB&T Securities’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$401K	Buy	10,928 +1,778	+19%	+$53.9K	﹤0.01%	1192
2019 Q2	$244K	Sell	9,150 -2,001	-18%	-$51.1K	﹤0.01%	1422
2019 Q1	$299K	Buy	+11,151	New	+$260K	﹤0.01%	1296
2018 Q4	–	Sell	-17,049	Closed	-$353K	–	1475
2018 Q3	$353K	Sell	17,049 -1,569	-8%	-$24.7K	﹤0.01%	1256
2018 Q2	$284K	Buy	18,618 +3,613	+24%	+$64.4K	﹤0.01%	1304
2018 Q1	$337K	Buy	15,005 +2,347	+19%	+$65K	﹤0.01%	1191
2017 Q4	$381K	Buy	12,658 +7,295	+136%	+$233K	0.01%	1091
2017 Q3	$202K	Sell	5,363 -5,540	-51%	-$180K	﹤0.01%	1295
2017 Q2	$304K	Buy	+10,903	New	+$325K	﹤0.01%	1140